Phase Ib Dose-confirmation Study of ASLAN001 Combined With Weekly Paclitaxel and Carboplatin in Advanced Solid Tumours, Followed by an Open-label Phase II Study in Patients With Stage I-III HER2 Positive Breast Cancer
Phase of Trial: Phase I/II
Latest Information Update: 29 Jun 2016
At a glance
- Drugs Varlitinib (Primary) ; Carboplatin; Paclitaxel
- Indications Breast cancer; Male breast cancer
- Focus Therapeutic Use
- 07 Jun 2017 Biomarkers information updated
- 21 Jun 2016 Planned End Date changed from 1 Mar 2018 to 1 Mar 2019.
- 21 Jun 2016 Planned primary completion date changed from 1 Mar 2017 to 1 Mar 2018.